The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients by Thygesen, Sandra K et al.
RESEARCH ARTICLE Open Access
The predictive value of ICD-10 diagnostic coding
used to assess Charlson comorbidity index
conditions in the population-based Danish
National Registry of Patients
Sandra K Thygesen
1*, Christian F Christiansen
1, Steffen Christensen
1, Timothy L Lash
1,2 and Henrik T Sørensen
1,2
Abstract
Background: The Charlson comorbidity index is often used to control for confounding in research based on
medical databases. There are few studies of the accuracy of the codes obtained from these databases.
We examined the positive predictive value (PPV) of the ICD-10 diagnostic coding in the Danish National Registry of
Patients (NRP) for the 19 Charlson conditions.
Methods: Among all hospitalizations in Northern Denmark between 1 January 1998 and 31 December 2007 with a
first-listed diagnosis of a Charlson condition in the NRP, we selected 50 hospital contacts for each condition. We
reviewed discharge summaries and medical records to verify the NRP diagnoses, and computed the PPV as the
proportion of confirmed diagnoses.
Results: A total of 950 records were reviewed. The overall PPV for the 19 Charlson conditions was 98.0% (95% CI;
96.9, 98.8). The PPVs ranged from 82.0% (95% CI; 68.6%, 91.4%) for diabetes with diabetic complications to 100%
(one-sided 97.5% CI; 92.9%, 100%) for congestive heart failure, peripheral vascular disease, chronic pulmonary
disease, mild and severe liver disease, hemiplegia, renal disease, leukaemia, lymphoma, metastatic tumour, and
AIDS.
Conclusion: The PPV of NRP coding of the Charlson conditions was consistently high.
Background
Comorbidities are coexistent diseases to a disease of
interest [1] or index disease [2]. Comorbidities may
directly affect the prognosis of the disease of interest, or
may indirectly affect the prognosis by affecting the
choice of treatment [1-3].
An index of comorbidity level has the advantage of
bringing several comorbidities into a single numeric
score, thereby reducing the number of candidate vari-
ables into a manageable set of proxy variables, which is
especially beneficial when using administrative databases
or medical registries [4,5]. The Charlson comorbidity
index is the most widely used comorbidity index [3,6]. It
was developed to predict 1-year mortality among 604
medical patients based on comorbidity data obtained
from hospital chart review in a single US hospital in
1984 [6]. The 19 Charlson conditions were selected and
weighted according to their potential influence on mor-
tality and validated for predicting 1-year mortality in a
cohort of 685 breast cancer patients [6]. Since then, the
Charlson comorbidity index has been adapted for use
with data from administrative databases and medical
registries that record medical conditions using the Inter-
national Classification of Diseases, 9
th revision (ICD-9),
a Clinical Modification of ICD-9 (ICD-9-CM) [7,8], and
recently also the International Classification of Diseases,
10
th revision (ICD-10) [9-11].
Only two studies have examined the accuracy of diag-
nosis coding of Charlson comorbidity conditions in
administrative hospital registries compared with
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Quan et al [12] was carried out in 1996-1997 in Calgary,
Canada using ICD-9 diagnosis codes, but the results
may not necessarily hold today for European registries
using ICD-10 codes. Henderson et al. assessed the qual-
ity of coding in Victoria, Australia soon after the imple-
mentation of ICD-10 in 1998-2001 compared with ICD-
9 coding in the earlier years and found high coding
quality in both time periods [13].
Medical registries and administrative databases offer
an important resource for studies of public health issues
[14]. Scandinavian population-based medical registries
can be linked using unique personal identifiers and are
therefore used extensively for epidemiologic research
[15,16]. Data collection and coding procedures may vary
across countries [17], and no Nordic study has validated
the coding procedure on all conditions included in the
Charlson comorbidity index. Measuring comorbidity
accurately is important, since controlling for confound-
ing by comorbidity affects the validity of such epidemio-
logic studies [3,18]. Sufficient control for confounding
requires high data quality [19].
We therefore conducted this study to assess the posi-
tive predictive value (PPV) of the coding of each of the
19 Charlson comorbidity conditions assessed by ICD-10
diagnoses from a population-based medical registry.
Methods
Study population
This study was conducted in the North Jutland Region,
Denmark using patients with diagnoses registered in the
Danish National Registry of Patients (NRP) between 1
January 1998 and 31 December 2007. The population of
this region is approximately 500,000 people, correspond-
ing to about 11% of the total Danish population. The
Danish population receives tax-supported health care
without additional charge.
The National Registry of Patients
The Danish NRP includes data on all non-psychiatric
hospital admissions in Denmark since 1977 and outpati-
ent clinic and emergency room visits since 1995. The
NRP includes data on date of admissions and discharges,
surgical procedures performed, and up to 20 diagnoses
classified according to the International Classification of
Diseases, 8
th revision (ICD-8) until the end of 1993 and
10
th revision (ICD-10) thereafter. The physician who
discharges the patient reviews the medical record and
makes a discharge summary including discharge diag-
noses coded using ICD codes. ICD codes are then
entered by the medical secretary into the hospital regis-
try. From there, the data are electronically transmitted
to the NRP at the National Board of Health (Figure 1)
[16,20].
We used the NRP to identify all hospital contacts
(comprising both in- and outpatients) in the study
population with one of the Charlson comorbidity condi-
tions as a first-listed diagnosis [21]. We did not make
Figure 1 Coding process during an admission to a hospital in
Denmark.
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room contacts and patients followed in outpatient
clinics. According to Danish practice, the first-listed
diagnosis in the discharge record is the main reason for
the hospital contact. For each of the 19 Charlson
comorbidity conditions, we selected randomly five hos-
pital contacts per year in the ten year study period,
yielding a total of 950 hospital contacts.
We used the patient’s unique personal identification
number and date of admission and discharge to identify
the discharge summary for each of the 950 hospital con-
tacts. The discharge summary describes the most impor-
tant events during the hospital contact, including reason
for admission, diagnostic work-up, treatment, prescribed
medications, and plan after discharge [22]. All discharge
summaries were reviewed by the same physician (SKT).
Record review
The review of the discharge summary and medical
record began with a confirmation of the personal identi-
fication number and the date of admission and dis-
charge for the hospital contact retrieved from the NRP.
We then proceeded with confirmation of the diagnosis.
We considered a diagnosis to be confirmed if the dis-
charge summary described the exact diagnosis or a diag-
nosis within the same Charlson comorbidity condition.
For example, if a discharge summary or medical record
indicated non-insulin dependent diabetes mellitus, and
this disease was coded as insulin dependent diabetes
mellitus in the NRP, then the diagnosis was considered
to be confirmed because the Charlson comorbidity
index does not distinguish between non-insulin depen-
dent and insulin dependent diabetes mellitus. If the
diagnosis was not described in the discharge summary
or if the discharge summary was not available, then the
medical record was reviewed to determine whether the
diagnosis code could be confirmed. Discharge summa-
ries from outpatient clinic contacts may only include a
description of treatment, and in these cases the medical
record was retrieved. When the reviewing physician had
any doubt about whether the discharge summary or
medical record agreed with the NRP ICD-10 code, the
discharge summary or medical record was reviewed by a
second physician (CFC), and the two physicians reached
a consensus agreement. The review process was con-
ducted twice for all patients by SKT (second review was
done to check for typing errors).
Statistical analysis
We assessed the accuracy of the ICD-10 diagnostic codes
in the NRP by comparison with the discharge summary
or medical record, which were considered the reference
standard. We quantified the accuracy by computing the
positive predictive value and its corresponding 95%
confidence intervals (CI), calculated with Clopper-Pear-
son binomial confidence intervals [23]. The positive pre-
dictive value was the proportion of Charlson comorbidity
conditions identified in the record contacts collected
f r o mt h eN R Pt h a tc o u l db ec o n f i r m e di nt h ed i s c h a r g e
summary or in the medical record.
We stratified the analyses by age, sex, and inpatients
and outpatients both separately and together to eluci-
date any differences in the PPV. We also report the pro-
portion of cases for whom the medical record was
retrieved, for both inpatients and outpatients.
Data were entered in EpiData (EpiData Association,
Odense, Denmark, http://www.epidata.dk) and analysed
with STATA version 9.2 (StataCorp, College Station,
Texas, USA). The study was approved by The Danish
Data Protection Agency (record number: 2006-53-1396)
Results
From the 950 diagnoses codes from the NRP we identi-
fied all 950 hospital contacts. Of these 588 (61.9%) were
inpatients and 362 (38.1%) were outpatients. 65 (6.8%)
patients were younger than 18 years of age. Of those
most had leukemia (20 patients) or hemiplegia (16
patients) and the rest included diabetes mellitus, chronic
pulmonary disease, connective tissue disease, moderate
to severe renal disease, AIDS, lymphoma and any
tumor. Discharge summaries needed more information
to confirm the registry diagnosis in 238 (25%) of the
contacts so the medical record was reviewed for these.
The overall positive predictive value for the first-listed
diagnosis included in the 19 Charlson comorbidity con-
ditions was 98.0% (95% CI; 96.9%, 98.8%). The PPV for
the first-listed diagnoses in each of the Charlson comor-
bidity conditions ranged from 82.0% (95% CI; 68.6%,
91.4%) for diabetes mellitus with diabetic complications
to 100% (one-sided 97.5% CI 92.2%, 100%) for conges-
tive heart failure, peripheral vascular disease, chronic
pulmonary disease, mild and severe liver disease, hemi-
plegia, renal disease, leukaemia, lymphoma, metastatic
tumour and AIDS (Table 1). We found virtually no dif-
ferences when stratifying in- and outpatients by each of
the Charlson comorbidity condition.
When estimating the coding accuracy according to
each stratum, we found a PPV of 98.6 (95% CI; 97.3%,
99.4%) for inpatients and 97.0 (95% CI; 94.6%, 98.5%)
for outpatients. In females the PPV was 98.2% (95% CI;
96.5%, 99.2%) and in males 97.8% (95% CI; 96.1%,
98.9%). The PPVs were 100% (one-sided 97.5% CI;
94.5%, 100%) for patients aged below 18 years, 97.4%
(95% CI; 94.0%, 99.1%) for patients aged 18 to 49 years,
97.3% (95% CI; 94.4%, 98.9%) for patients aged 50 to 64
years, 99.0% (95% CI; 96.5%, 99.9%) for patients aged 65
to 74 years, and 97.9% (95% CI; 95.1%, 99.3%) for
patients 75 years or older.
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tion of the diagnosis in 36.2% of outpatients, but only
18.2% of inpatients.
Discussion
We found a positive predictive value greater than 90%
for almost all ICD-10 diagnostic codes used to ascertain
the Charlson comorbidity conditions in the NRP. This
accuracy is better than the accuracy reported in earlier
studies [12,13].
Our study was conducted in an area with virtually
complete data from the population-based administrative
registries on all hospitalized patients during the study
period. We examined patients admitted to hospitals in
one region in Denmark, but do not expect that rates of
coding errors would differ across the regions. We
sampled the same number of discharge summaries and
medical records from each of the ten years of the study
period, and the NRP data were of excellent quality
throughout the time period. We validated the 19 condi-
tions included in the Charlson comorbidity index, which
were selected by Charlson because they were important
predictors of one-year mortality risk. This set of condi-
tions, therefore, contains serious diseases that are readily
diagnosed. The excellent PPV of these diagnostic codes
in the NRP may not apply to less severe conditions
recorded in the NRP. Furthermore, wrong coded diag-
noses within the same Charlson category were consid-
ered confirmed, as errors of this type would not affect
the Charlson comorbidity index score. Finally, we veri-
fied the discharge physicians’ coding compared with the
description in the discharge summary or medical record
(Figure 1), but did not examine whether the diagnostic
criteria were actually fulfilled.
We found almost twice as many outpatients as inpati-
ents, who needed the entire medical journal to be
retrieved for confirmation of the registry recorded diag-
nosis. The reason was that the physician often continued
Table 1 Positive predictive value (PPV) of the National Registry of Patients (NRP) first-listed ICD codes for the
Charlson comorbidities
Charlson condition Corresponding International Classification of
Diseases, 10
th revision codes
Number of correct coded
contacts/number reviewed
PPV % (95% CI)* First-
listed diagnoses
All Charlson conditions 931/950 98.0 (96.9 - 98.8)
Myocardial infarction I21;I22;I23 49/50 98.0 (89.4 - 99.9)
Congestive heart failure I50; I11.0; I13.0; I13.2 50/50 100 (92.9 - 100)
Peripheral vascular disease I70; I71; I72; I73; I74; I77 50/50 100 (92.9 - 100)
Cerebrovascular disease I60-I69; G45; G46 47/50 94.0 (83.5 - 98.7)
Dementia F00-F03; F05.1; G30 49/50 98.0 (89.4 - 99.9)
Chronic pulmonary disease J40-J47; J60-J67; J68.4; J70.1; 50/50 100 (92.9 - 100)
J70.3; J84.1; J92.0; J96.1; J98.2; J98.3
Connective tissue disease M05; M06; M08; M09;M30;M31; 49/50 98.0 (89.4 - 99.9)
M32; M33; M34; M35; M36; D86
Ulcer disease K22.1; K25-K28 49/50 98.0 (89.4 - 99.9)
Mild liver disease B18; K70.0-K70.3; K70.9; K71; K73; K74; K76.0 50/50 100 (92.9 - 100)
Diabetes mellitus E10.0, E10.1; E10.9 48/50 96.0 (86.3 - 99.5)
E11.0; E11.1; E11.9
Hemiplegia G81; G82 50/50 100 (92.9 - 100)
Moderate/severe renal
disease
I12; I13; N00-N05; N07; N11; N14; N17-N19; Q61 50/50 100 (92.9 - 100)
Diabetes mellitus with
chronic complications
E10.2-E10.8 41/50 82.0 (68.6 - 91.4)
E11.2-E11.8
Any tumor C00-C75 49/50 98.0 (89.4 - 99.9)
Leukemia C91-C95 50/50 100 (92.9 - 100)
Lymphoma C81-C85; C88; C90; C96 50/50 100 (92.9 - 100)
Moderate/severe liver
disease
B15.0; B16.0; B16.2; B19.0; K70.4; K72; K76.6; I85 50/50 100 (92.9 - 100)
Metastatic solid tumor C76-C80 50/50 100 (92.9 - 100)
AIDS B21-B24 50/50 100 (92.9 - 100)
*When the PPV is 100%, a one-sided 97.5% confidence interval was estimated.
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was more often a short note, answers on blood tests etc.
and often the diagnosis was not mentioned. Sometimes a
note just showed that the patient missed his/her
appointment.
The diagnosis code was known to the physician
reviewer before reviewing the discharge summary.
When in doubt, this may affect the judgement of the
diagnostic coding in favour of a confirmation and we
cannot rule this out as a possible partial explanation of
the high PPVs. We have no information on patients
with a Charlson comorbidity condition that was not
diagnosed at a hospital; however, this concern is unlikely
to influence our results because patients with these ser-
ious diseases are likely to have had previous hospital
contact. Because we do not have un-coded patients, fx.
a patient with diabetes hospitalized with a pneumonia
may not always be coded with diabetes, we are unable
to estimate the negative predictive value, sensitivity, or
specificity, which are also important measures of validity
of administrative hospital discharge databases [24].
Diabetes mellitus with diabetic complications had the
lowest PPV, mainly because the diabetic complications
could not be confirmed in the discharge summary or
the medical record. For example, dysregulation of dia-
betes was typically interpreted as a complication without
specification. A previous Danish study found a higher
PPV of diabetes registration (insulin dependent diabetes
mellitus of 96.3 (95% CI; 95.5-97.2) and noninsulin
dependent diabetes mellitus of 97.9% (95% CI; 97.2;
98.5)) [25], however, they did not study the misclassifi-
cation of the complications related to diabetes mellitus.
Two earlier studies have validated the quality of diag-
nostic coding in administrative databases used to ascer-
tain Charlson comorbidities [12,13] and one validated
the coding process according to the ICD-10-AM. Hen-
derson et al [13] assessed the quality of coding in routi-
nely collected hospital discharge data in Australia based
on ICD-10-AM for 1998-1999 (n = 7,004) and in 2000-
2001 (n = 7,631). Their PPV (2000-2001) ranged from
62% (95% CI; 48, 76) for peripheral vascular disease to
94% (95% CI; 91, 97) for metastatic cancer. Their PPV
for HIV was not included, as there were no prevalent
cases. The validation study was completed shortly after
the implementation of ICD-10 to examine whether the
data quality was maintained or improved. Our study
started 4 years after the implementation of ICD-10,
which may explain our consistently higher PPVs.
The Canadian study [12] validated the quality of diag-
nostic coding on administrative data using the ICD-9-
CM diagnoses included in the Charlson comorbidity
index. The study was conducted in 1996-1997 including
1,200 inpatients in Calgary, Alberta. They found a PPV
ranging from 44.0% to 96.3%. Some of the Charlson
comorbidities were associated with considerable coding
errors and were based on ICD-9-CM, which is not as
widely used as the ICD-10. PPV values were found
lower than 50% for liver disease (both mild and moder-
ate to severe) and rheumatologic diseases.
Humphries et al [26] validated 7 of the Charlson
comorbidities in 817 patients undergoing percutaneous
coronary intervention at a single hospital from 1994-
1995. The study was based on ICD-9-CM and their PPV
ranged from 50.6% to 93.3% using the patient chart
review data as the reference standard.
Several Danish studies have estimated the PPV of
selected diagnoses included in the Charlson comorbidity
index (e.g. acute myocardial infarction [27], cerebrovas-
cular disease [28,29], dementia [30], rheumatoid arthritis
[31], liver cirrhosis [32], diabetes mellitus [25], cancer
[33], haematological malignancies [34] and HIV [35]) in
the NRP and generally report of lower PPV’st h a ni n
our study. These studies validated diagnoses using strict
diagnostic criteria, requiring for example specific clinical
investigations. If these specific diagnostic criteria were
not satisfied, then a patient was classified as not having
the disease, even if the physician had diagnosed and
treated the patient for that disease. These other studies
were therefore meant to validate diagnoses, whereas we
were validating ICD-10 codes against the diagnosis
assigned by the treating physician. The difference in
objective may explain the lower accuracies reported in
these other Danish studies.
Conclusion
The PPV of diagnosis coding in the Danish NRP for
conditions included in the Charlson comorbidity index
is very high. The high positive predictive value in our
study suggests that the NRP ICD-10 diagnostic codes
are coded very accurately in comparison to the dis-
charge physician’s diagnosis. We could not, however,
confirm whether the diagnosis was correct. The high
accuracy supports the use of ICD-10 codes in future
research to control for confounding by comorbidity as
measured by the Charlson comorbidity index.
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